Clinical Trial: Early Prophylactic Aspirin for Aneurysmal Subarachnoid Hemorrhage

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07642427) titled 'Early Prophylactic Aspirin for Aneurysmal Subarachnoid Hemorrhage' on May 28.

Brief Summary: This study is a multicenter, prospective, double-blind, randomized controlled trial designed to evaluate whether early prophylactic use of aspirin improves functional outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH). Patients with aSAH who have undergone successful aneurysm securing will be randomly assigned to receive either aspirin plus standard care or a placebo plus standard care. The study drug will be started within 48 hours of undergone successful aneurysm securing and continued for not less than 10 days and not mor...